Health Canada has approved Shire Pharma’s Vyvanse for the treatment of moderate-to-severe binge eating disorder in adults.

Vyvanse provides a new treatment option to Canadian physicians in addition to the psychotherapies that are currently available to treat adults with moderate-to-severe binge eating disorder.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

Ottawa Hospital Regional Centre for the Treatment of Eating Disorders director Dr Hany Bissada said: “Binge eating disorder is a serious mental illness with devastating impacts, including on one’s self-esteem.

“Affected patients tend to present with other serious psychological conditions such as depression and anxiety, or conditions associated with metabolic syndrome, like diabetes for example.”

“We are pleased to … hopefully help address some of the unmet needs of Canadian adults living with moderate-to-severe binge eating disorder.”

Binge eating is recognised as a distinct disorder in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition and is defined as recurring episodes of consuming more food in a short time.

During a binge eating episode, patients feel a lack of control and distress over their eating.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The disorder occurs in men, as well as women and is more common than anorexia and bulimia combined and can also occur in normal weight, overweight, and obese adults.

Shire Canada general manager Eric Tse said: “We are pleased to make this new treatment option available in Canada, and hopefully help address some of the unmet needs of Canadian adults living with moderate-to-severe binge eating disorder.”